A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
Titel:
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG
Auteur:
Banerjee, S. Rustin, G. Paul, J. Williams, C. Pledge, S. Gabra, H. Skailes, G. Lamont, A. Hindley, A. Goss, G. Gilby, E. Hogg, M. Harper, P. Kipps, E. Lewsley, L-A Hall, M. Vasey, P. Kaye, S.B.